Sprint Bioscience Q1: A highly intense period - Redeye

2025 has turned out to be a very intense period so far, including a SEK 23m fundraising, publications, a strategic review, the announced discontinued Day One collaboration and a subsequent review, including reducing the operational costs. The proactive approach after the Day One announcement is positive, and there is pressure to secure new partners shortly.

Länk till analysen i sin helhet: https://www.redeye.se/research/1112778/sprint-bioscience-q1-a-highly-intense-period?utm_source=finwire&utm_medium=RSS